Preclinical Testing of Living Tissue-Engineered Heart Valves for Pediatric Patients, Challenges and Opportunities

Introduction: Pediatric patients with cardiac congenital diseases require heart valve implants that can grow with their natural somatic increase in size. Current artificial valves perform poorly in children and cannot grow; thus, living-tissue-engineered valves capable of sustaining matrix homeostas...

Descripción completa

Detalles Bibliográficos
Autores principales: Movileanu, Ionela, Harpa, Marius, Al Hussein, Hussam, Harceaga, Lucian, Chertes, Alexandru, Al Hussein, Hamida, Lutter, Georg, Puehler, Thomas, Preda, Terezia, Sircuta, Carmen, Cotoi, Ovidiu, Nistor, Dan, Man, Adrian, Cordos, Bogdan, Deac, Radu, Suciu, Horatiu, Brinzaniuc, Klara, Casco, Megan, Sierad, Leslie, Bruce, Margarita, Simionescu, Dan, Simionescu, Agneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416773/
https://www.ncbi.nlm.nih.gov/pubmed/34490371
http://dx.doi.org/10.3389/fcvm.2021.707892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416773/
https://www.ncbi.nlm.nih.gov/pubmed/34490371
http://dx.doi.org/10.3389/fcvm.2021.707892

Ejemplares similares